01 Aug 2022 Policy

One Cancer Voice writes to Sajid Javid ahead of 10-Year Cancer Plan

Today, with over 50 cancer charities, we wrote to the Secretary of State for Health & Social Care, Sajid Javid, to set out our expectation for next month’s 10-Year Cancer Plan.

The 10-Year Cancer Plan must include robust, fully costed and funded plans to deliver on its ambitions, and set out how it will address shortages in workforce and equipment – key hurdles that have hindered previous commitments and strategies.

We are writing alongside other charities including Blood Cancer UK, Cancer Research UK and Leukaemia Care, to urge Sajid Javid to ensure the plan meets the ten essential tests we set out in our submission as being ‘essential to deliver on your ambition of having the best cancer care in Europe.’

The key tests to which the whole cancer community will hold this 10-Year Cancer Plan include, ensuring the plan is fully planned, costed and funded, that there are no more shortages in the cancer workforce, and that it matches ambition with accountability.

This 10-Year Cancer Plan comes at a very important time for those affected by cancer in England, with the continued ‘devastating impact of the pandemic on cancer services’ – particularly on waiting times for care.

New survey data from Cancer Research UK shows that 3 in 4 (75%) adults in the UK don’t think the NHS has enough staff or equipment to deal with cancer. Rising cancer incidence over the 10 years of the Plan indicates the challenge ‘is only set to grow – meaning tangible, decisive action is needed now.’

We urge Sajid Javid to ensure the 10-Year Cancer Plan meets these tests, if it is to have the full support, belief and backing of the wider cancer community.

Read the full letter.

Related posts

Improving access to life-changing treatment – Leukaemia UK’s role in the approval of Aucatzyl

25 November 2025

Improving access to life-changing treatment – Leukaemia UK’s role in the approval of Aucatzyl

Today, NICE announced its recommendation for Aucatzyl (obecabtagene autoleucel), a CAR-T therapy, to be made available on the NHS for treating adults aged 26 and over with relapsed or refractory…

Widespread coverage of new leukaemia therapy shows promise in first trial patient

12 December 2022

Widespread coverage of new leukaemia therapy shows promise in first trial patient

As you may have seen in the news over the weekend, a clinical trial investigating a new leukaemia treatment has shown promising results. As part of the trial, funded by…

Pedalling pair’s crazy peaks challenge to stop leukaemia cutting short the lives of beloved mums

1 August 2022

Pedalling pair’s crazy peaks challenge to stop leukaemia cutting short the lives of beloved mums

Leukaemia UK supporter, Alistair, who lost is mum to leukaemia less than a year ago, is setting out on an extreme fundraising challenge. Alistair, who is from Lincoln, and his…

Leukaemia UK appoints new CEO

27 August 2020

Leukaemia UK appoints new CEO

The trustees of Leukaemia UK are delighted to announce that they have appointed Fiona Hazell as CEO of Leukaemia UK. Fiona brings a strong track record in not-for-profit leadership, starting her role on 9th September 2020.